Primary Site >> Colorectal Cancer

Gene >> PARP2

Journal: Radiat Oncol. 2012 Apr 23;7:62.
Title: The combination of olaparib and camptothecin for effective radiosensitization.
Author: Miura, Katsutoshi|Sakata, Koh-ichi|Someya, Masanori|Matsumoto, Yoshihisa|Matsumoto, Hideki|Takahashi, Akihisa|Hareyama, Masato
PMID: 22524618
Journal: Cancer Cell Int. 2015 Feb 4;15(1):14.
Title: Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status.
Author: Genther Williams, Sybil M|Kuznicki, Apryle M|Andrade, Paula|Dolinski, Brian M|Elbi, Cem|O'Hagan, Ronan C|Toniatti, Carlo
PMID: 25685067
Journal: Cancer Chemother Pharmacol. 2018 Oct;82(4):635-647.
Title: Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1.
Author: Jain, Mukul R|Mohapatra, Jogeswar|Bandhyopadhyay, Debdutta|Chatterjee, Abhijit|Ghoshdastidar, Krishnarup|Patel, Dinesh|Patel, Ankit|Bhayani, Hitesh|Srivastava, Brijesh Kumar|Shedage, Sandeep A|Kadam, Pravin|Sundar, Rajesh|Patel, Harilal|Giri, Poonam|Patel
PMID: 30046848